Shares Magazine
26.56p-0.24 (-0.91%)31 Dec 2024, 08:32
Jump to:
Ekf Diagnostics Holdings PLC Fundamentals
| Company Name | Ekf Diagnostics Holdings PLC | Last Updated | 2024-12-31 |
|---|---|---|---|
| Industry | Medical Devices | Sector | Healthcare |
| Shares in Issue | 453.731 m | Market Cap | £120.49 m |
| PE Ratio | 25.28 | Dividend per Share | £0.01 |
| Dividend Yield | 0 | Dividend Cover | 0.43 |
| EPS | £0.01 | EPS Growth (%) | 0 |
| PEG | 0 | DPS Growth (%) | 0 |
| Debt Ratio | 0.0157 | Debt Equity Ratio | 0.0147 |
| Asset Equity Ratio | 1.1343 | Cash Equity Ratio | 0.1085 |
| Quick Ratio | 2.6392 | Current Ratio | 4.60 |
| Price To Book Value | 1.7674 | ROCE | 0 |
Ekf Diagnostics Holdings PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|---|---|---|---|---|
| Prelim | 2023-11-02 | 2023-12-01 | GBP | 0.0120 | |
| Prelim | 2022-11-03 | 2022-12-01 | GBP | 0.0120 |
Ekf Diagnostics Holdings PLC Company Financials
| Assets | 2023 | 2022 | 2021 |
|---|---|---|---|
| Tangible Assets | £24.77 m | £21.71 m | £17.87 m |
| Intangible Assets | £30.22 m | £33.77 m | £41.89 m |
| Investments | £276,000.00 | £1.12 m | £7.79 m |
| Total Fixed Assets | £55.29 m | £57.53 m | £67.56 m |
| Stocks | £8.77 m | £9.43 m | £13.24 m |
| Debtors | £6.23 m | £8.59 m | £11.13 m |
| Cash & Equivalents | £6.02 m | £9.21 m | £20.34 m |
| Other Assets | £18,000.00 | £925,000.00 | £15,000.00 |
| Total Assets | £80.85 m | £89.29 m | £115.12 m |
| Liabilities | 2023 | 2022 | 2021 |
|---|---|---|---|
| Creditors within 1 year | £9.50 m | £11.74 m | £13.65 m |
| Creditors after 1 year | £3.13 m | £3.03 m | £6.73 m |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | £12.63 m | £14.77 m | £20.38 m |
| Net assets | £68.22 m | £74.52 m | £94.74 m |
| Equity | 2023 | 2022 | 2021 |
|---|---|---|---|
| Called up share capital | £4.54 m | £4.55 m | £4.64 m |
| Share Premium | £7.38 m | £7.38 m | £7.38 m |
| Profit / Loss | £2.13 m | -£8.94 m | £21.43 m |
| Other Equity | £67.12 m | £73.35 m | £94.12 m |
| Preference & Minorities | £1.10 m | £1.18 m | £618,000.00 |
| Total Capital Employed | £68.22 m | £74.52 m | £94.74 m |
| Ratios | 2023 | 2022 | 2021 |
|---|---|---|---|
| Debt Ratio | £0.01 | £0.01 | £0.02 |
| Debt-to-Equity | £0.01 | £0.01 | £0.02 |
| Assets / Equity | 1.1343 | 1.1343 | 1.1343 |
| Cash / Equity | 0.1085 | 0.1085 | 0.1085 |
| EPS | £0.01 | £-0.00 | £0.04 |
| Cash Flow | 2023 | 2022 | 2021 |
|---|---|---|---|
| Cash from operating activities | £6.31 m | £9.69 m | £10.24 m |
| Cashflow before financing | £2.67 m | -£1.35 m | £4.08 m |
| Increase in Cash | -£2.98 m | -£10.28 m | -£1.39 m |
| Income | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | £52.61 m | £66.64 m | £81.84 m |
| Cost of sales | £28.75 m | £42.60 m | £42.47 m |
| Gross Profit | £23.86 m | £24.04 m | £39.37 m |
| Operating Profit | £2.08 m | -£8.97 m | £21.75 m |
| Pre-Tax profit | £2.13 m | -£8.94 m | £21.43 m |
Ekf Diagnostics Holdings PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | EKF Diagnostics Holdings PLC is engaged in the field of medical diagnostics. Its businesses are Point-of-Care, Central Laboratory, Life Sciences, and Contract Manufacturing. It caters to companies focused on areas such as diabetes, Hematology, Infectious diseases, Clinical Chemistry, Life Sciences OEM, Sports medicine, Custom Bioprocessing, and Others. The company derives its income from its sales in the United States. Its other markets include Germany, Poland, and Russia. |
| Latest Interim Date | 17 Sep 2024 |
| Latest Fiscal Year End Date | 20 Mar 2024 |
Ekf Diagnostics Holdings PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2016-04-08 | Mr. Ron Zwanziger | Non-Executive Director |
| 2015-04-28 | Mr. Gordon James Hall | Non-Executive Director |
| 2024-03-25 | Mr. Christopher Harwood Bernard Mills | Non-Executive Director |
| 2015-11-20 | Dr. Kevin William Wilson | Non-Executive Director |
| 2021-05-19 | Mr. Adam Reynolds | Non-Executive Director |
| 2015-12-02 | Mr. Paul Andrew Peter Foulger | Executive Director,Finance Director and Company Secretary |
| 2024-04-22 | Mr. Julian Huw Baines MBE | Executive Director,Chairman |
| 2017-04-18 | Mr. David Eric Evans | Non-Executive Director,Deputy Chairman |
| 2015-12-30 | Dr. Tito Bacarese-Hamilton | Executive Director,Chief Technology Officer |
| 2011-08-09 | Mr. Anthony Hutchinson | Executive Director,Chief Executive |
| 2024-04-22 | Mr. Stephen Michael Young | Executive Director,Chief Financial Officer |
| 2021-12-29 | Mr. Richard Anthony Evans | Executive Director,Finance Director and Chief Operating Officer |
| 2017-04-18 | Mr. Salim Hamir | Company Secretary |
| 2023-02-06 | Mr. David Michael Salter | Executive Director,Chief Executive Officer |
Ekf Diagnostics Holdings PLC Contact Details
| Company Name | EKF Diagnostics Holdings PLC |
|---|---|
| Address | 19 Stanwell Road, Penarth, Avon House, Cardiff, CF64 2EZ |
| Telephone | +44 2920710570 |
| Website | https://www.ekfdiagnostics.com |
Ekf Diagnostics Holdings PLC Advisors
| Bank | HSBC Bank PLC |
|---|
| Nominated Adviser | N+1 Singer |
|---|---|
| Phone | +44 2074963000 |
| Fax | +44 2074963150 |
| Stockbroker | N+1 Singer |
|---|---|
| Phone | +44 2074963000 |
| Fax | +44 2074963150 |
| Auditor | PricewaterhouseCoopers LLP |
|---|---|
| Phone | +44 2920237000 |
| Fax | +44 2920802400 |
| Registrar | Link Asset Services |
|---|---|
| Phone | +44 8716640300 |
| Fax | +44 2086392342 |
| Financial PR Adviser | Walbrook PR |
|---|---|
| Phone | +44 2079338780 |
| Fax | +44 2079338781 |
| Solicitor | Berry Smith Solicitors |
|---|---|
| Phone | (02920) 345 511 |
| Fax | (02920) 345 945 |
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Sthree PLC | 291.00 | 3.37 |
| Oxford Nanopore Technologies PLC | 128.70 | 2.71 |
| Kainos Group PLC | 797.00 | 2.44 |
| Rathbones Group PLC | 1,684.00 | 2.43 |
| Foresight Environmental Infrastructure Limited | 73.45 | 2.16 |
| Quilter PLC | 153.90 | 2.12 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| W.A.G Payment Solutions PLC | 78.00 | -2.50 |
| Nb Private Equity Partners Limited | 1,555.72 | -1.29 |
| Diversified Energy Company PLC | 1,319.36 | -1.17 |
| Worldwide Healthcare Trust PLC | 314.60 | -1.22 |
| Pphe Hotel Group Limited | 1,382.00 | -0.93 |
| Ashtead Group PLC | 4,885.00 | -0.93 |